PRA was selected to perform a Phase II colorectal cancer trial due to our knowledge from previous colorectal studies as well as our evidence-based approach. In only a few months, our new client experienced PRA’s commitment open communication and engaging relationships and our determination to meet critical deadlines. These qualities are now the foundation of our very successful partnership.
PRA Revs Up Multiple Myeloma Study
A large biotech company selected PRA to conduct 2 global Phase III open-label studies to measure the safety and efficacy of a multiple myeloma drug.…
PRA Health Sciences Investor Relations
IIT Program Management Case Study
6+ year relationship with a large biopharma company that needed to change the operating model for their investigator-initiated trials (IIT), in part…